Wednesday, December 11, 2024
12:00 PM - 12:45 PM
All Levels
Regis A. James, PhD, has spent well over a decade building scalable, end-to-end AI systems in domains ranging from molecular diagnostics of genetic disease patients to electroretinogram hallmark extraction from mouse models to company-wide employee pairing for institutional knowledge transfer (mentor matching). In doing so, the contexts in which he has collaborated have presented numerous opportunities to develop and implement circumspect practices for effective due diligence towards reducing the risk and, therefore, maximizing the explainability of ultimate decisions. To demonstrate these principles, Regis will discuss how these considerations were applied in MAGNETRON AI, a recent patent-pending autonomous AI system that he built with colleagues, and highlight how these principles can be re-applied within other institutional contexts.
Topics covered:
I build autonomous AI systems that we teach to recommend/make complex, data-driven decisions for humans, achieving valued outcomes.
At Regeneron Pharmaceuticals, a world-class developer of therapeutic biologics, I work as a full-stack data scientist to make medicine and optimize clinical trial logistics by collaborating with colleagues to bring structure to and extract meaning from biological data, helping illuminate nonobvious underlying relationships. I initiate novel and facilitate existing projects towards the accelerated extraction of actionable biological and therapeutic insights. I personally, and collaboratively with fellow scientists, write code to develop, optimize, and integrate AI pipeline efforts that result in the generation of impactful and user-friendly scientific business decision support software tools.
Additionally, I coordinate the advising of other data scientists via a community of practice on the development of their own novel data science webtools and the support of the computational platforms on which this work is accomplished.